SCHEMBL23217109

SCHEMBL23217109

COC(=O)CCCCNC(=O)Nc1ccc(S(=O)(=O)N2CCN(c3cc(Cl)cc(C(F)(F)F)c3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 3/20 0.46
EPHX2 P34913 2/20 0.46
USP2 O75604 1/20 0.46
GAA P10253 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 1/20 0.46
PTGDR Q13258 1/20 0.45
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 3/20 0.44
HSD17B10 Q99714 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44
ATM Q13315 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217124 0.91 PTPN11 (0.49) NAMPTMEN1KMT2AMAPTEPHX2
SCHEMBL23217375 0.89 NAMPT (0.47) NAMPTMEN1KMT2AMAPTEPHX2
SCHEMBL23217315 0.89 LMNA (0.52) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL23217117 0.87 MAPT (0.53) MEN1KMT2AMAPTGAACA1
SCHEMBL23217303 0.86 NAMPT (0.44) NAMPTMEN1KMT2AMAPTEPHX2
SCHEMBL23217370 0.83 CA1 (0.47) NAMPTMAPTEPHX2CA1CA2
SCHEMBL30563199 0.81 MAPT (0.66) MEN1KMT2AMAPTEPHX2USP2
SCHEMBL25381894 0.81 MAPT (0.66) MEN1KMT2AMAPTEPHX2USP2
SCHEMBL23217131 0.80 PTPN11 (0.55) NAMPTMEN1KMT2AMAPTGAA
SCHEMBL23217419 0.79 LMNA (0.49) NAMPTMEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2024-04-18 US disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME CFH, LPAR3, CBR3 NAMPT 1265/4885MEN1 2071/4885KMT2A 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.